#
|
Entity
|
Type
|
Relation
|
Support
|
Relative specificity
|
1
|
ERBB3 gene
|
Gene
|
Known
|
Explain
|
|
2
|
CCNE1 gene
|
Gene
|
Known
|
Explain
|
|
3
|
CDKN1B gene
|
Gene
|
Known
|
Explain
|
|
4
|
BIRC5 gene
|
Gene
|
Known
|
Explain
|
|
5
|
ERBB2 gene
|
Gene
|
Known
|
Explain
|
|
6
|
CCND1 gene
|
Gene
|
Known
|
Explain
|
|
7
|
CDK2 gene
|
Gene
|
Known
|
Explain
|
|
8
|
Malignant neoplasm of breast
|
Disease
|
Known
|
Explain
|
|
9
|
MAPK3 gene
|
Gene
|
Known
|
Explain
|
|
10
|
AKT1 gene
|
Gene
|
Known
|
Explain
|
|
11
|
EGFR gene
|
Gene
|
Known
|
Explain
|
|
12
|
MAPK1 gene
|
Gene
|
Known
|
Explain
|
|
13
|
ESR1 gene
|
Gene
|
Known
|
Explain
|
|
14
|
CP-654577
|
Compound
|
Inferred
|
Explain
|
|
15
|
EB 1089
|
Compound
|
Inferred
|
Explain
|
|
16
|
6-(methylamino)pyrido(3,4-d)pyrimidine
|
Compound
|
Inferred
|
Explain
|
|
17
|
CB 1093
|
Compound
|
Inferred
|
Explain
|
|
18
|
Butyl Methyl Ketones
|
Compound
|
Inferred
|
Explain
|
|
19
|
indole-3-carbinol
|
Compound
|
Inferred
|
Explain
|
|
20
|
CMF regimen
|
Other
|
Inferred
|
Explain
|
|
21
|
CDKN1A gene
|
Gene
|
Inferred
|
Explain
|
|
22
|
allose
|
Compound
|
Inferred
|
Explain
|
|
23
|
Epirubicin
|
Compound
|
Inferred
|
Explain
|
|
24
|
equiguard
|
Compound
|
Inferred
|
Explain
|
|
25
|
RB1 gene
|
Gene
|
Inferred
|
Explain
|
|
26
|
fludarabine
|
Compound
|
Inferred
|
Explain
|
|
27
|
Oligomycins
|
Compound
|
Inferred
|
Explain
|
|
28
|
L 868275
|
Compound
|
Inferred
|
Explain
|
|
29
|
Prostate cancer - Homo sapiens (human)
|
Pathway
|
Inferred
|
Explain
|
|
30
|
SB 203580
|
Compound
|
Inferred
|
Explain
|
|
31
|
FTI 277
|
Compound
|
Inferred
|
Explain
|
|
32
|
panduratin A
|
Compound
|
Inferred
|
Explain
|
|
33
|
PD 98059
|
Compound
|
Inferred
|
Explain
|
|
34
|
CDK4 gene
|
Gene
|
Inferred
|
Explain
|
|
35
|
Folfox protocol
|
Other
|
Inferred
|
Explain
|
|
36
|
LY 294002
|
Compound
|
Inferred
|
Explain
|
|
37
|
KH 1060
|
Compound
|
Inferred
|
Explain
|
|
38
|
ErbB signaling pathway - Homo sapiens (human)
|
Pathway
|
Inferred
|
Explain
|
|
39
|
betulinic acid
|
Compound
|
Inferred
|
Explain
|
|
40
|
2-hydroxy-9-cis-octadecenoic acid
|
Compound
|
Inferred
|
Explain
|
|
41
|
N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide
|
Compound
|
Inferred
|
Explain
|
|
42
|
Butyrates
|
Compound
|
Inferred
|
Explain
|
|
43
|
Protein Binding
|
Function
|
Inferred
|
Explain
|
|
44
|
HS 1030
|
Compound
|
Inferred
|
Explain
|
|
45
|
HS-1199
|
Compound
|
Inferred
|
Explain
|
|
46
|
wortmannin
|
Compound
|
Inferred
|
Explain
|
|
47
|
HS 1183
|
Compound
|
Inferred
|
Explain
|
|
48
|
Berberine
|
Compound
|
Inferred
|
Explain
|
|
49
|
Pathways in cancer - Homo sapiens (human)
|
Pathway
|
Inferred
|
Explain
|
|
50
|
HS 1200
|
Compound
|
Inferred
|
Explain
|
|
51
|
6-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid
|
Compound
|
Inferred
|
Explain
|
|
52
|
Vorinostat
|
Compound
|
Inferred
|
Explain
|
|
53
|
oxaliplatin
|
Compound
|
Inferred
|
Explain
|
|
54
|
Quercetin
|
Compound
|
Inferred
|
Explain
|
|
55
|
1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene
|
Compound
|
Inferred
|
Explain
|
|
56
|
resveratrol
|
Compound
|
Inferred
|
Explain
|
|
57
|
Tamoxifen
|
Compound
|
Inferred
|
Explain
|
|
58
|
CDK1 gene
|
Gene
|
Inferred
|
Explain
|
|
59
|
Curcumin
|
Compound
|
Inferred
|
Explain
|
|
60
|
Doxorubicin
|
Compound
|
Inferred
|
Explain
|
|
61
|
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline
|
Compound
|
Inferred
|
Explain
|
|
62
|
4-hydroxytamoxifen
|
Compound
|
Inferred
|
Explain
|
|
63
|
Deferoxamine
|
Compound
|
Inferred
|
Explain
|
|
64
|
CDK6 gene
|
Gene
|
Inferred
|
Explain
|
|
65
|
tanespimycin
|
Compound
|
Inferred
|
Explain
|
|
66
|
hypsiziprenol A9
|
Compound
|
Inferred
|
Explain
|
|
67
|
CASP3 gene
|
Gene
|
Inferred
|
Explain
|
|
68
|
MAPK14 gene
|
Gene
|
Inferred
|
Explain
|
|
69
|
Alkaline Hematin D-575
|
Compound
|
Inferred
|
Explain
|
|
70
|
receptor signaling protein tyrosine kinase activity
|
Function
|
Inferred
|
Explain
|
|
71
|
beta-hexachlorocyclohexane
|
Compound
|
Inferred
|
Explain
|
|
72
|
lactacystin
|
Compound
|
Inferred
|
Explain
|
|
73
|
TP53 gene
|
Gene
|
Inferred
|
Explain
|
|
74
|
PS 341
|
Compound
|
Inferred
|
Explain
|
|
75
|
CASP9 gene
|
Gene
|
Inferred
|
Explain
|
|
76
|
2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone
|
Compound
|
Inferred
|
Explain
|
|
77
|
butylidenephthalide
|
Compound
|
Inferred
|
Explain
|
|
78
|
Lung Neoplasms
|
Disease
|
Inferred
|
Explain
|
|
79
|
Cytomel
|
Compound
|
Inferred
|
Explain
|
|
80
|
Calcium Phytate
|
Compound
|
Inferred
|
Explain
|
|
81
|
Cell Nucleus
|
Component
|
Inferred
|
Explain
|
|
82
|
Estradiol
|
Compound
|
Inferred
|
Explain
|
|
83
|
CB 403
|
Compound
|
Inferred
|
Explain
|
|
84
|
lycopene
|
Compound
|
Inferred
|
Explain
|
|
85
|
ZM 182780
|
Compound
|
Inferred
|
Explain
|
|
86
|
S-farnesylthiosalicylic acid
|
Compound
|
Inferred
|
Explain
|
|
87
|
Small cell lung cancer - Homo sapiens (human)
|
Pathway
|
Inferred
|
Explain
|
|
88
|
Staurosporine
|
Compound
|
Inferred
|
Explain
|
|
89
|
deguelin
|
Compound
|
Inferred
|
Explain
|
|
90
|
Cholecalciferol
|
Compound
|
Inferred
|
Explain
|
|
91
|
Tyrosine protein kinase, receptor-type, EGF/ERB/XmrK
|
Domain
|
Inferred
|
Explain
|
|
92
|
ginsenoside Rg1
|
Compound
|
Inferred
|
Explain
|
|
93
|
Tretinoin
|
Compound
|
Inferred
|
Explain
|
|
94
|
AR gene
|
Gene
|
Inferred
|
Explain
|
|
95
|
SRC gene
|
Gene
|
Inferred
|
Explain
|
|
96
|
4-(1H-imidazol-1-yl)retinoic acid
|
Compound
|
Inferred
|
Explain
|
|
97
|
CCNA2 gene
|
Gene
|
Inferred
|
Explain
|
|
98
|
Non-small cell lung cancer - Homo sapiens (human)
|
Pathway
|
Inferred
|
Explain
|
|
99
|
Tetradecanoylphorbol Acetate
|
Compound
|
Inferred
|
Explain
|
|
100
|
ESR2 gene
|
Gene
|
Inferred
|
Explain
|
|